LinkinLegal
Graham Robinson photo

Graham Robinson

Graham Robinson is an M&A partner in the Boston office of Kirkland & Ellis LLP. Graham’s practice focuses on transactions involving the acquisitions of public companies, specifically within the biopharmaceutical industry. He is ranked first by deal value and number of deals among U.S. attorneys for public biotechnology M&A transactions since January 2016, according to Deal Point Data. Graham also has extensive experience within the shareholder activism space. He has helped companies prepare for and respond to unsolicited acquisition proposals, as well as dealing with activist investors. He provides counsel to boards of directors and special committees on corporate governance matters and internal investigations. · Kirkland & Ellis LLP

United StatesM&A: Large Deals ($1bn+), Shareholder Activism

About

Graham Robinson is an M&A partner in the Boston office of Kirkland & Ellis LLP. His practice focuses on transactions involving the acquisitions of public companies, specifically within the biopharmaceutical industry. He is ranked first by deal value and number of deals among U.S. attorneys for public biotechnology M&A transactions since January 2016, according to Deal Point Data. Graham also has extensive experience within the shareholder activism space. He has helped companies prepare for and respond to unsolicited acquisition proposals, as well as dealing with activist investors. He provides counsel to boards of directors and special committees on corporate governance matters and internal investigations.

Practice areas

M&A: Large Deals ($1bn+)Shareholder Activism

Office

Expertise

M&A: Large Deals ($1bn+)Shareholder Activism

Education

  • Harvard Law School, J.D., 1999
  • University of Pennsylvania, B.A., 1996